OMC
IRWD icon

Old Mission Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Old Mission Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-179,706
Closed -$2.1M – 1477
2021
Q4 		$2.1M Sell
179,706
-39,302
-18% -$482K 0.09% 229
2021
Q3 		$2.86M Buy
219,008
+88,646
+68% +$1.15M 0.12% 162
2021
Q2 		$1.68M Buy
+130,362
New +$1.49M 0.06% 287

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Old Mission Capital's IRWD Position: Q1 2022 in Review

Old Mission Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2022, closing a stake of 179,706 shares — an estimated $2.1M sold.

Old Mission Capital first reported a position in IRWD in Q2 2021 and held it in 3 quarters. The position peaked at $2.86M in Q3 2021. 221 funds tracked by Wall St. Rank hold IRWD as of Q1 2022.

  • Old Mission Capital reported no remaining Ironwood Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Old Mission Capital sold 179,706 Ironwood Pharmaceuticals shares in Q1 2022, an estimated $2.1M.
  • Old Mission Capital first reported a position in Ironwood Pharmaceuticals in Q2 2021 and held it in 3 quarters.
  • Old Mission Capital's Ironwood Pharmaceuticals position peaked at $2.86M in Q3 2021.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2022.

Based on Old Mission Capital's 13F filing for Q1 2022, filed 13 May 2022.